Recently, selective laser trabeculoplasty (SLT) has been demonstrated to lower the intraocular pressure (IOP) and medication use in NTG. The purpose of this study was to investigate the efficacy ...

Purpose: To compare outcomes of selective laser trabeculoplasty (SLT) with drug therapy for glaucoma patients in a prospective randomized clinical trial. Patients and Methods: Sixty-nine patients ...

After 6 years of follow-up, patients randomized to selective laser trabeculoplasty (SLT) had a 29% lower rate of glaucoma progression versus eye drop therapy. The rate of fast progression was more ...

New data support a change in management of the common eye disease glaucoma from eye drops, the current standard of care, to a ...

"Selective laser trabeculoplasty should not only be considered ... prompted us to test again the previously observed ...

Ask ophthalmologist Dr. Lauren Kaplan if eye exams are important and she will give a resounding “yes.” A medical doctor ...

Like Selective Laser Trabeculoplasty (SLT), DSLT therapy delivers laser energy to the trabecular meshwork. Voyager™ DSLT’s proprietary eye-tracking technology ensures an accurate, automated ...

CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops ...

Recently, Alcon expanded its glaucoma portfolio with the Voyager™ DSLT (formerly the Belkin Eagle). Like Selective Laser Trabeculoplasty (SLT), DSLT therapy delivers laser energy to the trabecular ...